Baby Cereal Sold at Walmart Recalled for Elevated Levels of Arsenic
WEDNESDAY, Oct. 13, 2021 (HealthDay News) -- Maple Island Inc. announced Friday that it has recalled three lots of Parent's Choice Rice Baby Cereal because of elevated levels of arsenic in the products.
A sample from the three lots, which were sold only at Walmart, tested above the guidance for naturally occurring inorganic arsenic, according to a company announcement on the recall from Maple Island that was posted on the U.S. Food and Drug Administration website. The heavy metal has been tied to impaired development in children.
"Research has shown reducing exposure to toxic elements is important to minimizing any potential long-term effects on the developing brains of infants and children," the recall stated. "FDA has recognized that trace elements such as these are widely present in the environment, including water, soil and food."
The 8 oz. lots being recalled were sold after April 5, 2021, and include:
- Lot 21083 with UPC Code #00681131082907 with a best if used by date of JUN 24 2022.
- Lot 21084 with UPC Code #00681131082907 with a best if used by date of JUN 25 2022.
- Lot 21242 with UPC Code #00681131082907 with a best if used by date of NOV 30 2022.
The best if used by date and product numbers are on the bottom left corner on the back of the Parent's Choice Rice Baby Cereal packaging, the company said in a statement announcing the recall. No illnesses related to the recalled products have been reported, according to Maple Island. Customers who bought the recalled baby cereal should throw it out or return it to Walmart for a full refund, the company said.
Consumers can call Maple Island Monday through Friday, from 8 a.m. to 4 p.m. Central time, at 1-800-369-1022.
Related Posts
AI Model Can Diagnose Obstructive Sleep Apnea
THURSDAY, Oct. 20, 2022 (HealthDay News) -- A random forest (RF) model has...
Opioid Tapering May Have Unintended Negative Consequences
MONDAY, Feb. 13, 2023 (HealthDay News) -- For patients prescribed long-term...
FTD-TPI Plus Bevacizumab Increases Survival in Refractory Advanced CRC
THURSDAY, May 4, 2023 (HealthDay News) -- Treatment with trifluridine-tipiracil...
Encuentran el herbicida glifosato en la orina de la mayoría de los estadounidenses
MARTES, 12 de julio de 2022 (HealthDay News) -- Más del 80 por ciento de los...